A
Avijit Lahiri
Researcher at Wellington Hospital
Publications - 276
Citations - 10234
Avijit Lahiri is an academic researcher from Wellington Hospital. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 53, co-authored 273 publications receiving 9923 citations. Previous affiliations of Avijit Lahiri include Northwick Park Hospital.
Papers
More filters
Journal ArticleDOI
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable?
N G Bellenger,Malcolm I. Burgess,Simon Ray,Avijit Lahiri,Andrew J.S. Coats,John G.F. Cleland,Dudley J. Pennell +6 more
TL;DR: The results suggest that cardiovascular magnetic resonance is the preferred technique for volume and ejection fraction estimation in heart failure patients, because of its 3D approach for non-symmetric ventricles and superior image quality.
Journal ArticleDOI
Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy.
Dhakshinamurthy Vijay Anand,Eric Lim,David Hopkins,Roger Corder,Leslee J. Shaw,Patrick Sharp,DP Lipkin,Avijit Lahiri +7 more
TL;DR: Subclinical atherosclerosis, measured by CAC imaging, is superior to the established cardiovascular risk factors for predicting silent myocardial ischaemia and short-term outcome and its cost effectiveness is warranted.
Journal ArticleDOI
Detection of Coronary Artery Disease With Myocardial Contrast Echocardiography Comparison With 99mTc-Sestamibi Single-Photon Emission Computed Tomography
TL;DR: This study shows that MCE, with venous injection of contrast, can define the presence of CAD during rest and pharmacological stress and holds promise for the noninvasive assessment of myocardial perfusion in humans.
Journal Article
Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
Brian Higley,Francis W. Smith,T. Smith,Howard G. Gemmell,Prabir Das Gupta,Dragouten V. Gvozdanovic,David I. Graham,David A. Hinge,J. Davidson,Avijit Lahiri +9 more
TL;DR: Technetium-99m-tetrofosmin can produce high quality myocardial images from 5 min to several hours postinjection, and clearance is excellent from blood, liver, liver and lung.
Journal ArticleDOI
Cardiovascular Outcome in White-Coat Versus Sustained Mild Hypertension A 10-Year Follow-Up Study
TL;DR: Findings indicate a relatively benign outcome in white-coat hypertension compared with sustained mild hypertension, and subgroup analysis in patients without complications revealed a lower incidence of left ventricular hypertrophy and lesser degrees of carotidhypertrophy in thewhite-coat group.